Back to DRIEHAUS CAPITAL MANAGEMENT LLC

PTGX
Showing 8 of 10 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC

DRIEHAUS CAPITAL MANAGEMENT LLC holds 720,928 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $76M as of 2026-Q1. The position was decreased (-34.4% shares). PTGX represents 0.6% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$76M

Current Shares

720,928

Total Value Change

+$56.7M

Total Shares Change

+164,093

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
720,928
-34.4%
$76M0.6%$91.30
0
2025-Q4
Decreased
1.1M
-3.6%
$96M0.7%$87.26
0
2025-Q3
Increased
1.1M
+50.4%
$75.7M0.5%$65.14
58
2025-Q2
Increased
757,710
+222.3%
$41.9M0.3%$55.69
56
2025-Q1
Decreased
235,073
-30.8%
$11.4M0.1%$48.88
0
2024-Q4
Decreased
339,698
-23.7%
$13.1M0.1%$38.51
0
2024-Q3
Decreased
445,352
-20.0%
$20M0.2%$44.56
0
2024-Q2
Decreased
556,835
-0.7%
$19.3M0.2%$34.65
0

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used